Clinical trial for Diagnoses Disease
Official title Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers
ClinicalTrials.gov ID: NCT04891029
What this study is testing
- What it's testing
- The study will determine whether the test can accurately identify early cancer in the general population.
- Who it's for
- The study looks for women who are peri‑ or post‑menopausal and do not have symptoms of cancer.
- What's involved
- Participants will provide a uterine sample and a saliva sample for the test. Results will be reviewed and any needed follow‑up will be arranged.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 75, women only. Healthy volunteers may be eligible.
You may be able to join if
- \- Capacity to understand study and provide informed consent
You likely can't join if
- Prior hysterectomy
- Be pregnant
- Be nursing
- Be undergoing any fertility treatment
- Have had recent history of uterine perforation
The study team makes the final eligibility decision.
Where it is enrolling
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 45 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Montreal, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.